Tekla Life Sciences Inves... (HQL)
NYSE: HQL
· Real-Time Price · USD
16.58
0.13 (0.79%)
At close: Oct 16, 2025, 3:59 PM
16.58
0.00%
After-hours: Oct 16, 2025, 04:10 PM EDT
Tekla Life Sciences Investors Ratios and Metrics
Financials in USD. Fiscal
year is
October - September.
Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
Period Ending | Mar 31, 2025 | Sep 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.94 | 3.10 | 1.83 | -7.29 | 2.70 | -3.1 | -1.36 | 3.89 | 3.79 |
Forward PE Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PEG Ratio | 0.01 | -0.09 | -0.00 | 0.05 | -0.01 | 0.05 | 0.00 | 1.26 | -0.06 |
PS Ratio | 20.13 | 226.61 | 178.52 | 11.30 | 189.26 | 16.17 | 40.89 | 32.11 | 16.48 |
PB Ratio | 0.93 | 0.94 | 0.84 | 0.83 | 0.86 | 0.88 | 0.96 | 0.98 | 0.95 |
P/FCF Ratio | -350.64 | n/a | n/a | n/a | n/a | n/a | n/a | -1.38B | -1.29B |
P/OCF Ratio | -350.64 | n/a | n/a | n/a | n/a | n/a | n/a | -1.38B | -1.29B |
Price to Fair Value | 0.93 | 0.94 | 0.84 | 0.83 | 0.86 | 0.88 | 0.96 | 0.98 | 0.95 |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.00 | n/a |
Debt to Assets Ratio | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.00 | n/a |
Debt to Capital Ratio | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.00 | n/a |
LT Debt to Capital Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt to Market Cap | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | n/a | 0.32 | 0.20 | n/a | -1.19 | -6.46 | -6.33 | 0.01 | -23.75 |
Current Ratio | n/a | 0.32 | 0.20 | n/a | 0.00 | 0.12 | 0.96 | 0.01 | 0.13 |
Cash Ratio | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.08 | 0.00 | 0.00 |
Solvency Ratio | -3.07 | 40.86 | 57.86 | -17.1 | 3.46 | -1.64 | -5.9 | 3.07 | 48.56 |
Asset Turnover | 0.04 | 0.00 | 0.00 | 0.07 | 0.00 | 0.05 | 0.02 | 0.03 | 0.06 |
Receivables Turnover | 2.85 | 8.29 | 18.28 | 5.86 | 150.51 | 34.79 | 3.28 | 106.29 | 5.37K |
Payables Turnover | n/a | 1.58K | 11.04 | n/a | n/a | 0.52 | 0.82 | 20.65 | 67.40 |
Inventory Turnover | n/a | n/a | n/a | n/a | n/a | 0.08 | 0.11 | n/a | 2.82 |
Fixed Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Working Capital Turnover | -59.96 | -2.91 | 0.95 | -11.86 | -0.27 | -9.38 | -1.89 | -3 | -106.37 |
Financial Leverage Ratio | 1.04 | 1.00 | 1.00 | 1.00 | 1.02 | 1.04 | 1.03 | 1.02 | 1.00 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Service Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.12 | 0.08 | 0.11 | -0.03 | 0.08 | -0.07 | -0.18 | 0.06 | 0.06 |
Return on Assets | -0.11 | 0.08 | 0.11 | -0.03 | 0.08 | -0.07 | -0.17 | 0.06 | 0.06 |
Return on Invested Capital | n/a | n/a | n/a | -0.03 | n/a | -0.07 | -0.17 | 0.06 | 0.06 |
OCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | -0.00 |
OCF/S Ratio | -0.06 | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | -0.00 |
FCF/OCF Ratio | 1.00 | n/a | n/a | n/a | n/a | n/a | n/a | 1.00 | 1.00 |
ST OCF Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
OCF Coverage Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a |
CapEx Coverage Ratio | -261.23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend & CapEx Coverage | -0.04 | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | -0.00 |
Dividend Yield | 0.08 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 |
Dividend Yield % | 7.64 | 6.43 | 5.12 | 5.13 | 4.59 | 4.83 | 4.90 | 4.04 | 4.31 |
Payout Ratio | -0.59 | 0.80 | 0.38 | -1.5 | 0.50 | -0.6 | -0.27 | 0.63 | 0.65 |
Dividend Per Share | 0.97 | 0.97 | 0.69 | 0.64 | 0.64 | 0.66 | 0.81 | 0.84 | 0.85 |
Gross Profit Margin | n/a | 1.00 | 1.00 | 0.91 | 1.00 | 0.88 | 0.71 | 0.81 | 0.90 |
EBIT Margin | -2.6 | -0.66 | 48.67 | -0.39 | -0.49 | -1.31 | -7.5 | 2.06 | 1.09 |
EBITDA Margin | -2.6 | n/a | 48.67 | -0.39 | n/a | -1.31 | -7.5 | 2.06 | 1.09 |
Operating Profit Margin | -2.6 | -0.66 | -0.32 | -0.39 | -0.49 | -1.31 | -7.5 | 2.06 | 1.09 |
Pretax Profit Margin | -2.6 | 18.30 | 24.33 | -0.39 | 17.52 | -1.31 | -7.5 | 2.06 | 1.09 |
Continuous Operations Margin | -2.6 | 18.30 | 24.33 | -0.39 | 17.52 | -1.31 | -7.5 | 2.06 | 1.09 |
Net Profit Margin | -2.6 | 18.30 | 24.33 | -0.39 | 17.52 | -1.31 | -7.5 | 2.06 | 1.09 |
Bottom Line Profit Margin | -2.6 | 18.30 | 24.33 | -0.39 | 17.52 | -1.31 | -7.5 | 2.06 | 1.09 |
FCF Margin | -0.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue Per Share | 0.63 | 0.07 | 0.08 | 1.10 | 0.07 | 0.84 | 0.40 | 0.65 | 1.20 |
Net Income Per Share | -1.64 | 1.22 | 1.84 | -0.43 | 1.29 | -1.1 | -3.03 | 1.34 | 1.30 |
Interest Debt Per Share | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.01 | 0.05 | n/a |
Cash Per Share | 0.42 | n/a | n/a | 0.57 | 0.46 | 1.28 | 0.90 | 0.70 | 0.04 |
Book Value Per Share | 13.71 | 15.98 | 16.13 | 15.00 | 16.12 | 15.49 | 17.32 | 21.22 | 20.70 |
Tangible Book Value Per Share | 13.71 | 15.98 | 16.13 | 15.00 | 16.12 | 15.49 | 17.32 | 21.22 | 20.70 |
Shareholders' Equity Per Share | 13.71 | 15.98 | 16.13 | 15.00 | 16.12 | 15.49 | 17.32 | 21.22 | 20.70 |
Operating Cash Flow Per Share | -0.04 | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | -0.00 |
CapEx Per Share | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Free Cash Flow Per Share | -0.04 | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | -0.00 |
Net Income / EBT | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
EBT / EBIT | 1.00 | -27.66 | -76.92 | 1.00 | -35.93 | 1.00 | 1.00 | 1.00 | 1.00 |
Effective Tax Rate | n/a | n/a | n/a | 0.00 | n/a | n/a | 0.00 | -0.00 | -0.00 |
EV Multiple | -7.76 | n/a | 3.67 | -29.18 | n/a | -12.39 | -5.45 | 15.60 | 15.17 |
Source: Financial Modeling Prep. Financial Sources.